Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients

The purpose of this study is to study the effect of zinc supplementation in end stage renal failure on hemocystein level.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

End Stage Renal Failure Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shiraz University Hemodialysis Center

Shiraz, Fars, 098, Iran

About this study

hemocystein increased in end stage renal failure and zinc involved in hemocystein metabolism thus zinc supplementation may be effective on hemocystein level.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

hemodialysis for 3 months
older than 18 years old
serum level of zinc less than 72.6 microgram/ l in men and less than 70 microgram/ l in female

Exclusion criteria

acute renal failre
malabsorption
history of steroid or cytotoxic consumption

Treatment and study plan

Zinc Supplement

Drug

in 50 patients zinc sulfate 220 mg per day orally for 6 weeks

Placebo

Drug

placebo daily for 6 weeks

Primary outcomes

decreased hemocystein level

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Shiraz University of Medical Sciences

Other

Registry information

Important dates

Study start: 2009
Study completion: 2009
First posted: Apr 9, 2010
Registry last updated: Apr 9, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed